October 13, 2026Stocks·Bullish·corporate
Biosynex exits safeguard procedure after plan validation
Biosynex, the former star of ultra-rapid Covid tests, has exited its safeguard (sauvegarde) procedure after the validation of its plan.
Detected & updated continuously · Source: Nebula
Story subjects
Biosynex